 |
PDBsum entry 1h9v
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system, membrane protein
|
PDB id
|
|
|
|
1h9v
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system, membrane protein
|
 |
|
Title:
|
 |
Human fc-gamma-receptor iia (fcgriia), monoclinic
|
|
Structure:
|
 |
Low affinity immunoglobulin gamma fc receptor ii-a. Chain: a. Fragment: immunoglobulin g binding domain residue 5-177. Synonym: fc-gamma rii-a, fcrii-a, igg fc receptor ii-a, fc-gamma- riia, cd32, cdw32. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Variant: high responder. Cellular_location: extracellular. Expressed in: escherichia coli. Expression_system_taxid: 469008. Other_details: refolded from inclusion bodies
|
|
Biol. unit:
|
 |
Monomer (from PDB file)
|
|
Resolution:
|
 |
|
3.00Å
|
R-factor:
|
not given
|
|
|
Authors:
|
 |
P.Sondermann,J.Kaiser,U.Jacob
|
Key ref:
|
 |
P.Sondermann
et al.
(2001).
Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.
J Mol Biol,
309,
737-749.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
21-Mar-01
|
Release date:
|
21-Jun-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P12318
(FCG2A_HUMAN) -
Low affinity immunoglobulin gamma Fc region receptor II-a from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
317 a.a.
172 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
309:737-749
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.
|
|
P.Sondermann,
J.Kaiser,
U.Jacob.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Once antigen is opsonised by IgG it is removed from the circulation by
Fcgamma-receptor expressing cells. Fcgamma-receptors are type I transmembrane
molecules that carry extracellular parts consisting of two or three
immunoglobulin domains. Previously solved structures of Fc-receptors reveal that
the N-terminal two Ig-like domains are arranged in a steep angle forming a
heart-shaped structure. The crystal structure of the
FcgammaRIII/hIgG1-Fc-fragment demonstrated that the Fc-fragment is recognised
through loops of the C-terminal receptor domain of the FcgammaRIII. As the
overall structure of the FcRs and their Ig ligands are very similar we modelled
the Ig complexes with FcgammaRI, FcgammaRII and FcepsilonRIalpha based on the
FcgammaRIII/hIgG1-Fc-fragment structure. The obtained models are consistent with
the observed biochemical data and may explain the observed specificity and
affinities.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Stereo ribbon representation of the sFcgRIII structure with residues relevant for IgG binding. The amino
acid residues of FcgRIII which contact IgG are shown in ball-and-stick representation. Residues contacting the Cg2-A
domain are coloured magenta and those contacting the Cg2-B domain green. Potential glycosylation sites are depicted
as cyan balls and the disulphide bridges in yellow. The termini are labelled and the b-strands are numbered consecu-
tively for the N-terminal domain in black and for the C-terminal domain in blue. The orientation is the same as
Figure 1 (upper left), except that it is rotated by approximately 180 ° around the axis perpendicular to the plane of
the paper. The Figure was created using MOLSCRIPT
37
and RASTER3D.
38
|
 |
Figure 5.
Figure 5. Surface analysis of the FcR structures. A surface analysis was performed using the program GRASP
39
with the crystal structures of FcgRIIa, FcgRIIb, FcgRIII and FceRIa as well as the modelled FcgRI. The colour coding
spans from hydrophobic (green) to hydrophilic (red) with potential glycosylation sites indicated as blue balls. The
viewpoint is indicated with respect to the front view, which shows an identical orientation as in Figure 2. The IgG
binding site is surrounded by a black box in the FcgRIII molecule. The unique hydrophobic region on the N-terminal
domain of FcgRIII is circled.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2001,
309,
737-749)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.D.Holdom,
A.M.Davies,
J.E.Nettleship,
S.C.Bagby,
B.Dhaliwal,
E.Girardi,
J.Hunt,
H.J.Gould,
A.J.Beavil,
J.M.McDonnell,
R.J.Owens,
and
B.J.Sutton
(2011).
Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcɛRI.
|
| |
Nat Struct Mol Biol,
18,
571-576.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.A.Niederer,
M.R.Clatworthy,
L.C.Willcocks,
and
K.G.Smith
(2010).
FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus.
|
| |
Ann N Y Acad Sci,
1183,
69-88.
|
 |
|
|
|
|
 |
S.T.Jung,
T.H.Kang,
and
G.Georgiou
(2010).
Efficient expression and purification of human aglycosylated Fcgamma receptors in Escherichia coli.
|
| |
Biotechnol Bioeng,
107,
21-30.
|
 |
|
|
|
|
 |
S.Bonetto,
L.Spadola,
A.G.Buchanan,
L.Jermutus,
and
J.Lund
(2009).
Identification of cyclic peptides able to mimic the functional epitope of IgG1-Fc for human Fc gammaRI.
|
| |
FASEB J,
23,
575-585.
|
 |
|
|
|
|
 |
F.Bibollet-Ruche,
B.A.McKinney,
A.Duverger,
F.H.Wagner,
A.A.Ansari,
and
O.Kutsch
(2008).
The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype.
|
| |
J Virol,
82,
10271-10278.
|
 |
|
|
|
|
 |
F.Nimmerjahn,
and
J.V.Ravetch
(2008).
Fcgamma receptors as regulators of immune responses.
|
| |
Nat Rev Immunol,
8,
34-47.
|
 |
|
|
|
|
 |
T.I.Arnon,
J.T.Kaiser,
A.P.West,
R.Olson,
R.Diskin,
B.C.Viertlboeck,
T.W.Göbel,
and
P.J.Bjorkman
(2008).
The crystal structure of CHIR-AB1: a primordial avian classical Fc receptor.
|
| |
J Mol Biol,
381,
1012-1024.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Y.Liu,
L.M.Pop,
and
E.S.Vitetta
(2008).
Engineering therapeutic monoclonal antibodies.
|
| |
Immunol Rev,
222,
9.
|
 |
|
|
|
|
 |
B.C.Viertlboeck,
S.Schweinsberg,
M.A.Hanczaruk,
R.Schmitt,
L.Du Pasquier,
F.W.Herberg,
and
T.W.Göbel
(2007).
The chicken leukocyte receptor complex encodes a primordial, activating, high-affinity IgY Fc receptor.
|
| |
Proc Natl Acad Sci U S A,
104,
11718-11723.
|
 |
|
|
|
|
 |
M.Lv,
Y.Li,
M.Yu,
Y.Sun,
Z.Lin,
C.Qiao,
Q.Luo,
X.Gu,
Y.Huang,
J.Feng,
and
B.Shen
(2007).
Structured to reduce the mitogenicity of anti-CD3 antibody based on computer-guided molecular design.
|
| |
Int J Biochem Cell Biol,
39,
1142-1155.
|
 |
|
|
|
|
 |
R.S.McIntosh,
J.Shi,
R.M.Jennings,
J.C.Chappel,
T.F.de Koning-Ward,
T.Smith,
J.Green,
M.van Egmond,
J.H.Leusen,
M.Lazarou,
J.van de Winkel,
T.S.Jones,
B.S.Crabb,
A.A.Holder,
and
R.J.Pleass
(2007).
The importance of human FcgammaRI in mediating protection to malaria.
|
| |
PLoS Pathog,
3,
e72.
|
 |
|
|
|
|
 |
G.A.Lazar,
W.Dang,
S.Karki,
O.Vafa,
J.S.Peng,
L.Hyun,
C.Chan,
H.S.Chung,
A.Eivazi,
S.C.Yoder,
J.Vielmetter,
D.F.Carmichael,
R.J.Hayes,
and
B.I.Dahiyat
(2006).
Engineered antibody Fc variants with enhanced effector function.
|
| |
Proc Natl Acad Sci U S A,
103,
4005-4010.
|
 |
|
|
|
|
 |
Y.Kaneko,
F.Nimmerjahn,
and
J.V.Ravetch
(2006).
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.
|
| |
Science,
313,
670-673.
|
 |
|
|
|
|
 |
A.Verdoliva,
D.Marasco,
A.De Capua,
A.Saporito,
P.Bellofiore,
V.Manfredi,
R.Fattorusso,
C.Pedone,
and
M.Ruvo
(2005).
A new ligand for immunoglobulin g subdomains by screening of a synthetic peptide library.
|
| |
Chembiochem,
6,
1242-1253.
|
 |
|
|
|
|
 |
I.Mosyagin,
I.Cascorbi,
R.Schaub,
T.Krüger,
and
M.Dettling
(2005).
Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms?
|
| |
J Clin Psychopharmacol,
25,
435-440.
|
 |
|
|
|
|
 |
R.S.Davis,
G.R.Ehrhardt,
C.M.Leu,
M.Hirano,
and
M.D.Cooper
(2005).
An extended family of Fc receptor relatives.
|
| |
Eur J Immunol,
35,
674-680.
|
 |
|
|
|
|
 |
J.M.Woof,
and
D.R.Burton
(2004).
Human antibody-Fc receptor interactions illuminated by crystal structures.
|
| |
Nat Rev Immunol,
4,
89-99.
|
 |
|
|
|
|
 |
P.Maillard,
J.P.Lavergne,
S.Sibéril,
G.Faure,
F.Roohvand,
S.Petres,
J.L.Teillaud,
and
A.Budkowska
(2004).
Fcgamma receptor-like activity of hepatitis C virus core protein.
|
| |
J Biol Chem,
279,
2430-2437.
|
 |
|
|
|
|
 |
B.D.Wines,
A.Gavin,
M.S.Powell,
M.Steinitz,
R.R.Buchanan,
and
P.Mark Hogarth
(2003).
Soluble FcgammaRIIa inhibits rheumatoid factor binding to immune complexes.
|
| |
Immunology,
109,
246-254.
|
 |
|
|
|
|
 |
G.A.Lazar,
S.A.Marshall,
J.J.Plecs,
S.L.Mayo,
and
J.R.Desjarlais
(2003).
Designing proteins for therapeutic applications.
|
| |
Curr Opin Struct Biol,
13,
513-518.
|
 |
|
|
|
|
 |
H.J.Gould,
B.J.Sutton,
A.J.Beavil,
R.L.Beavil,
N.McCloskey,
H.A.Coker,
D.Fear,
and
L.Smurthwaite
(2003).
The biology of IGE and the basis of allergic disease.
|
| |
Annu Rev Immunol,
21,
579-628.
|
 |
|
|
|
|
 |
J.R.Desjarlais,
and
G.A.Lazar
(2003).
Negative design for improved therapeutic proteins.
|
| |
Trends Biotechnol,
21,
425-427.
|
 |
|
|
|
|
 |
L.Presta
(2003).
Antibody engineering for therapeutics.
|
| |
Curr Opin Struct Biol,
13,
519-525.
|
 |
|
|
|
|
 |
N.M.van Sorge,
W.L.van der Pol,
and
J.G.van de Winkel
(2003).
FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy.
|
| |
Tissue Antigens,
61,
189-202.
|
 |
|
|
|
|
 |
F.Facchetti,
M.Cella,
S.Festa,
D.H.Fremont,
and
M.Colonna
(2002).
An unusual Fc receptor-related protein expressed in human centroblasts.
|
| |
Proc Natl Acad Sci U S A,
99,
3776-3781.
|
 |
|
|
|
|
 |
R.S.Davis,
G.Dennis,
M.R.Odom,
A.W.Gibson,
R.P.Kimberly,
P.D.Burrows,
and
M.D.Cooper
(2002).
Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family.
|
| |
Immunol Rev,
190,
123-136.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |